F18.988
Inhalant use, unspecified with other inhalant-induced disorder
Clinical Classification Guidelines
Inclusion Terms
- Inhalant-induced mild neurocognitive disorder
Medical Intelligence & Overview
Inhalant use refers to the inhalation of volatile substances to achieve psychoactive effects. When inhalants are misused, they can cause a range of health issues, including effects on brain function known as inhalant-induced neurocognitive disorders. The ICD-10 code F18.988 specifically addresses cases where inhalant use leads to mild neurocognitive impairment without a more specific diagnosis. Recognizing the implications of inhalant misuse is essential for understanding the associated health risks and seeking appropriate medical attention.
Causes & Symptoms
Clinical Causes: Frequent inhalation of chemical vapors from common household products such as glue, paint thinners, or aerosols. Prolonged or repeated inhalant abuse leading to brain effects. Lack of awareness regarding the health hazards of inhalant substances. Psychological factors, including stress, peer pressure, or substance use disorders. Accessibility of inhalant products, especially among adolescents and young adults.
Key Symptoms: Mild confusion or forgetfulness Difficulty concentrating or focusing Reduced attention span Memory lapses or forgetfulness Dizziness or lightheadedness Impaired judgment Mild changes in mood or behavior Physical symptoms such as headaches, nausea, or fatigue
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a thorough medical evaluation, including a detailed history of substance use and assessment of cognitive function. Healthcare providers may perform neuropsychological testing to identify mild neurocognitive deficits. Additional investigations, such as blood tests or imaging studies, can help rule out other causes of cognitive issues. Importantly, a clinician will consider the patient's history of inhalant exposure to establish an accurate diagnosis aligned with the ICD-10 code F18.988.
Treatment Protocols: Treatment strategies typically focus on removing the individual from inhalant exposure and supporting recovery of cognitive functions. Approaches may include:
Clinical Advice & FAQs
Billing Guidance
Is F18.988 a billable ICD-10 code?
Yes, F18.988 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F18.988?
Clinical documentation must specify the nature of Inhalant use, unspecified with other inhalant-induced disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference